Daybue to treat Rett syndrome
Drug Name: Daybue Indications: To treat Rett syndrome Active Ingredient: Trofinetide Company: Acadia Pharmaceuticals Inc Approval Date: 3/10/2023 More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217026s000lbl.pdf